Details of the Drug Combinations

General Information of This Drug (ID: DM7NPJS)

• Drug Name: Paliperidone (DM7NPJS)
• Synonyms: Xeplion; Invega Sustenna; Paliperidone palmitate; JNS-010; Paliperidone (depot injection, NanoCrystal); Paliperidone (injectable, NanoCrystal), Elan; Paliperidone (depot injection, NanoCrystal), Johnson & Johnson

Indication

Psychotic disorder; ICD 11: 6A20-6A25; Status: Approved [1]; Schizoaffective disorder; ICD 11: 6A21; Status: Approved [1]; Schizophrenia; ICD 11: 6A20; Status: Approved [2]

• Drug Type: Small molecular drug

List of Combinatorial Drugs (CBD) Containing This Drug

2 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Aripiprazole + Paliperidone	DCWOISJ	Aripiprazole	Immunoassay	[3]
Aripiprazole + Paliperidone	DCSA8GZ	Aripiprazole	Schizophrenia	[4]

References

• [1] Paliperidone FDA Label
• [2] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7258).
• [3] ClinicalTrials.gov (NCT02634463) Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone
• [4] ClinicalTrials.gov (NCT06060886) Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis